TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
Uroderma AB
Closing information (x1000 SEK)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
10,957
|
11,706
|
10,662 |
| Financial expenses |
2
|
15
|
4 |
| Earnings before taxes |
4,657
|
5,513
|
5,458 |
| EBITDA |
4,789
|
5,722
|
5,691 |
| Total assets |
10,969
|
10,252
|
9,819 |
| Current assets |
5,272
|
4,403
|
4,560 |
| Current liabilities |
910
|
850
|
1,806 |
| Equity capital |
10,059
|
9,402
|
8,013 |
| - share capital |
50
|
50
|
50 |
| Employees (average) |
5
|
3
|
3 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
91.7%
|
91.7%
|
81.6% |
| Turnover per employee |
2,191
|
3,902
|
3,554 |
| Profit as a percentage of turnover |
42.5%
|
47.1%
|
51.2% |
| Return on assets (ROA) |
42.5%
|
53.9%
|
55.6% |
| Current ratio |
579.3%
|
518.0%
|
252.5% |
| Return on equity (ROE) |
46.3%
|
58.6%
|
68.1% |
| Change turnover |
-749
|
1,044
|
1,562 |
| Change turnover % |
-6%
|
10%
|
17% |
| Chg. No. of employees |
2
|
0
|
0 |
| Chg. No. of employees % |
67%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.